Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Clinical trial design in head and neck cancer: what has the oncologist learned?.

The Lancet. Oncology

Adelstein DJ.
PMID: 22748271
Lancet Oncol. 2012 Jul;13(7):e318-23. doi: 10.1016/S1470-2045(12)70119-5. Epub 2012 Jun 28.

Chemotherapy has assumed an important role in multidisciplinary management of patients with head and neck cancer. Much recent progress is attributable to successful design and careful implementation of clinical trials. In addition to showing the efficacy of chemotherapy, trials...

Cite
Adelstein DJ. Clinical trial design in head and neck cancer: what has the oncologist learned?. Lancet Oncol. 2012;13(7):e318-23doi: 10.1016/S1470-2045(12)70119-5.
Adelstein, D. J. (2012). Clinical trial design in head and neck cancer: what has the oncologist learned?. The Lancet. Oncology, 13(7), e318-23. https://doi.org/10.1016/S1470-2045(12)70119-5
Adelstein, David J. "Clinical trial design in head and neck cancer: what has the oncologist learned?." The Lancet. Oncology vol. 13,7 (2012): e318-23. doi: https://doi.org/10.1016/S1470-2045(12)70119-5
Adelstein DJ. Clinical trial design in head and neck cancer: what has the oncologist learned?. Lancet Oncol. 2012 Jul;13(7):e318-23. doi: 10.1016/S1470-2045(12)70119-5. Epub 2012 Jun 28. PMID: 22748271.
Copy Download .nbib Format: NLM
[Head and neck cancer].

Ugeskrift for laeger

Specht L.
PMID: 9469972
Ugeskr Laeger. 1998 Feb 02;160(6):793.

No abstract available.

Cite
Specht L. Hoved- og halscancer. [Head and neck cancer]. Ugeskr Laeger. 1998;160(6):793
Specht, L. (1998). Hoved- og halscancer. [Head and neck cancer]. Ugeskrift for laeger, 160(6), 793.
Specht, L. "Hoved- og halscancer." [Head and neck cancer]. Ugeskrift for laeger vol. 160,6 (1998): 793.
Specht L. Hoved- og halscancer. [Head and neck cancer]. Ugeskr Laeger. 1998 Feb 02;160(6):793. Danish. PMID: 9469972.
Copy Download .nbib Format: NLM
Treatment of advanced cancer of the head and neck: don't give up.

American journal of surgery

Chambers RG.
PMID: 7425228
Am J Surg. 1980 Oct;140(4):478-9. doi: 10.1016/0002-9610(80)90195-6.

No abstract available.

Cite
Chambers RG. Treatment of advanced cancer of the head and neck: don't give up. Am J Surg. 1980;140(4):478-9doi: 10.1016/0002-9610(80)90195-6.
Chambers, R. G. (1980). Treatment of advanced cancer of the head and neck: don't give up. American journal of surgery, 140(4), 478-9. https://doi.org/10.1016/0002-9610(80)90195-6
Chambers, R G. "Treatment of advanced cancer of the head and neck: don't give up." American journal of surgery vol. 140,4 (1980): 478-9. doi: https://doi.org/10.1016/0002-9610(80)90195-6
Chambers RG. Treatment of advanced cancer of the head and neck: don't give up. Am J Surg. 1980 Oct;140(4):478-9. doi: 10.1016/0002-9610(80)90195-6. PMID: 7425228.
Copy Download .nbib Format: NLM
Impact of tumor budding in head and neck squamous cell carcinoma: A meta-analysis.

Head & neck

Zhu Y, Liu H, Xie N, Liu X, Huang H, Wang C, Hou J.
PMID: 30549142
Head Neck. 2019 Feb;41(2):542-550. doi: 10.1002/hed.25462. Epub 2018 Dec 14.

Tumor budding (TB) has been suggested as an adverse prognostic factor in head and neck squamous cell carcinoma (HNSCC). This meta-analysis evaluated the prognostic role of TB in HNSCC. We systematically reviewed the literatures of electronic databases and performed...

Cite
Zhu Y, Liu H, Xie N, et al. Impact of tumor budding in head and neck squamous cell carcinoma: A meta-analysis. Head Neck. 2018;41(2):542-550doi: 10.1002/hed.25462.
Zhu, Y., Liu, H., Xie, N., Liu, X., Huang, H., Wang, C., & Hou, J. (2019). Impact of tumor budding in head and neck squamous cell carcinoma: A meta-analysis. Head & neck, 41(2), 542-550. https://doi.org/10.1002/hed.25462
Zhu, Yue, et al. "Impact of tumor budding in head and neck squamous cell carcinoma: A meta-analysis." Head & neck vol. 41,2 (2019): 542-550. doi: https://doi.org/10.1002/hed.25462
Zhu Y, Liu H, Xie N, Liu X, Huang H, Wang C, Hou J. Impact of tumor budding in head and neck squamous cell carcinoma: A meta-analysis. Head Neck. 2019 Feb;41(2):542-550. doi: 10.1002/hed.25462. Epub 2018 Dec 14. PMID: 30549142.
Copy Download .nbib Format: NLM
Psychological issues in head and neck cancer survivors: Need for addressal in rehabilitation.

Oral oncology

Kar A, M R A, Bhaumik U, Rao VUS.
PMID: 32564916
Oral Oncol. 2020 Nov;110:104859. doi: 10.1016/j.oraloncology.2020.104859. Epub 2020 Jun 18.

Rehabilitation in head and neck cancer (HNC) survivors is a lengthy process, based on multiple correlates and is associated with multiple challenges. The authors have tried to depict the psychological issues associated with the rehabilitation of these patients. Problems...

Cite
Kar A, M R A, Bhaumik U, et al. Psychological issues in head and neck cancer survivors: Need for addressal in rehabilitation. Oral Oncol. 2020;110:104859doi: 10.1016/j.oraloncology.2020.104859.
Kar, A., M R, A., Bhaumik, U., & Rao, V. U. S. (2020). Psychological issues in head and neck cancer survivors: Need for addressal in rehabilitation. Oral oncology, 110104859. https://doi.org/10.1016/j.oraloncology.2020.104859
Kar, Ankita, et al. "Psychological issues in head and neck cancer survivors: Need for addressal in rehabilitation." Oral oncology vol. 110 (2020): 104859. doi: https://doi.org/10.1016/j.oraloncology.2020.104859
Kar A, M R A, Bhaumik U, Rao VUS. Psychological issues in head and neck cancer survivors: Need for addressal in rehabilitation. Oral Oncol. 2020 Nov;110:104859. doi: 10.1016/j.oraloncology.2020.104859. Epub 2020 Jun 18. PMID: 32564916.
Copy Download .nbib Format: NLM
Treatment of advanced head and neck cancer.

The New England journal of medicine

Fortin A, Audet N, Caouette R.
PMID: 15317900
N Engl J Med. 2004 Aug 19;351(8):829-31; author reply 829-31. doi: 10.1056/NEJM200408193510821.

No abstract available.

Cite
Fortin A, Audet N, Caouette R. Treatment of advanced head and neck cancer. N Engl J Med. 2004;351(8):829-31; author reply 829-31doi: 10.1056/NEJM200408193510821.
Fortin, A., Audet, N., & Caouette, R. (2004). Treatment of advanced head and neck cancer. The New England journal of medicine, 351(8), 829-31; author reply 829-31. https://doi.org/10.1056/NEJM200408193510821
Fortin, André, et al. "Treatment of advanced head and neck cancer." The New England journal of medicine vol. 351,8 (2004): 829-31; author reply 829-31. doi: https://doi.org/10.1056/NEJM200408193510821
Fortin A, Audet N, Caouette R. Treatment of advanced head and neck cancer. N Engl J Med. 2004 Aug 19;351(8):829-31; author reply 829-31. doi: 10.1056/NEJM200408193510821. PMID: 15317900.
Copy Download .nbib Format: NLM
Patient-Reported Toxic Effects-The Dawn of a New Era.

JAMA otolaryngology-- head & neck surgery

Worden FP.
PMID: 27149196
JAMA Otolaryngol Head Neck Surg. 2016 Jun 01;142(6):524-5. doi: 10.1001/jamaoto.2016.0666.

No abstract available.

Cite
Worden FP. Patient-Reported Toxic Effects-The Dawn of a New Era. JAMA Otolaryngol Head Neck Surg. 2016;142(6):524-5doi: 10.1001/jamaoto.2016.0666.
Worden, F. P. (2016). Patient-Reported Toxic Effects-The Dawn of a New Era. JAMA otolaryngology-- head & neck surgery, 142(6), 524-5. https://doi.org/10.1001/jamaoto.2016.0666
Worden, Francis P. "Patient-Reported Toxic Effects-The Dawn of a New Era." JAMA otolaryngology-- head & neck surgery vol. 142,6 (2016): 524-5. doi: https://doi.org/10.1001/jamaoto.2016.0666
Worden FP. Patient-Reported Toxic Effects-The Dawn of a New Era. JAMA Otolaryngol Head Neck Surg. 2016 Jun 01;142(6):524-5. doi: 10.1001/jamaoto.2016.0666. PMID: 27149196.
Copy Download .nbib Format: NLM
Sentinel lymph node biopsy for melanoma of the head and neck.

Expert review of anticancer therapy

Lentsch EJ, McMasters KM.
PMID: 14599090
Expert Rev Anticancer Ther. 2003 Oct;3(5):673-83. doi: 10.1586/14737140.3.5.673.

Since its first description nearly two centuries ago, melanoma has been a difficult disease to diagnose and treat. With the incidence and mortality rates slowly increasing, understanding this disease is more important than ever. Herein, the current diagnostic and...

Cite
Lentsch EJ, McMasters KM. Sentinel lymph node biopsy for melanoma of the head and neck. Expert Rev Anticancer Ther. 2003;3(5):673-83doi: 10.1586/14737140.3.5.673.
Lentsch, E. J., & McMasters, K. M. (2003). Sentinel lymph node biopsy for melanoma of the head and neck. Expert review of anticancer therapy, 3(5), 673-83. https://doi.org/10.1586/14737140.3.5.673
Lentsch, Eric J, and McMasters, Kelly M. "Sentinel lymph node biopsy for melanoma of the head and neck." Expert review of anticancer therapy vol. 3,5 (2003): 673-83. doi: https://doi.org/10.1586/14737140.3.5.673
Lentsch EJ, McMasters KM. Sentinel lymph node biopsy for melanoma of the head and neck. Expert Rev Anticancer Ther. 2003 Oct;3(5):673-83. doi: 10.1586/14737140.3.5.673. PMID: 14599090.
Copy Download .nbib Format: NLM
Prognostic tools for cancer survival: a secondary role for quality-of-life measurement.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Browman GP, Berrang T, Smith S.
PMID: 19451423
J Clin Oncol. 2009 Jun 20;27(18):2902-4. doi: 10.1200/JCO.2009.21.8438. Epub 2009 May 18.

No abstract available.

Cite
Browman GP, Berrang T, Smith S. Prognostic tools for cancer survival: a secondary role for quality-of-life measurement. J Clin Oncol. 2009;27(18):2902-4doi: 10.1200/JCO.2009.21.8438.
Browman, G. P., Berrang, T., & Smith, S. (2009). Prognostic tools for cancer survival: a secondary role for quality-of-life measurement. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27(18), 2902-4. https://doi.org/10.1200/JCO.2009.21.8438
Browman, George P, et al. "Prognostic tools for cancer survival: a secondary role for quality-of-life measurement." Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 27,18 (2009): 2902-4. doi: https://doi.org/10.1200/JCO.2009.21.8438
Browman GP, Berrang T, Smith S. Prognostic tools for cancer survival: a secondary role for quality-of-life measurement. J Clin Oncol. 2009 Jun 20;27(18):2902-4. doi: 10.1200/JCO.2009.21.8438. Epub 2009 May 18. PMID: 19451423.
Copy Download .nbib Format: NLM
Resilience: an essential element in head and neck cancer survivorship and quality of life.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

MacDonald C, Theurer JA, Fung K, Yoo J, Doyle PC.
PMID: 33201311
Support Care Cancer. 2021 Jul;29(7):3725-3733. doi: 10.1007/s00520-020-05873-4. Epub 2020 Nov 17.

PURPOSE: Individuals with head and neck cancer (HNCa) face myriad biopsychosocial challenges. Even after treatment completion, these challenges may cause continued disablement and diminished quality of life (QoL). Resilience may serve to minimize the disabling impact of HNCa and,...

Cite
MacDonald C, Theurer JA, Fung K, et al. Resilience: an essential element in head and neck cancer survivorship and quality of life. Support Care Cancer. 2020;29(7):3725-3733doi: 10.1007/s00520-020-05873-4.
MacDonald, C., Theurer, J. A., Fung, K., Yoo, J., & Doyle, P. C. (2021). Resilience: an essential element in head and neck cancer survivorship and quality of life. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 29(7), 3725-3733. https://doi.org/10.1007/s00520-020-05873-4
MacDonald, Chelsea, et al. "Resilience: an essential element in head and neck cancer survivorship and quality of life." Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 29,7 (2021): 3725-3733. doi: https://doi.org/10.1007/s00520-020-05873-4
MacDonald C, Theurer JA, Fung K, Yoo J, Doyle PC. Resilience: an essential element in head and neck cancer survivorship and quality of life. Support Care Cancer. 2021 Jul;29(7):3725-3733. doi: 10.1007/s00520-020-05873-4. Epub 2020 Nov 17. PMID: 33201311.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries